Nutriband to Showcase AVERSA(TM) Tech at Emerging Growth Conference
Nutriband Inc. to present at Emerging Growth Conference, showcasing AVERSA(TM) abuse-deterrent technology. A breakthrough in transdermal pharmaceutical products.
Nutriband's participation in the Emerging Growth Conference and its development of AVERSA(TM) technology are significant for investors and the pharmaceutical industry. The technology addresses the critical issue of drug abuse, offering a safer alternative for transdermal drug delivery. This innovation could lead to broader applications in preventing drug misuse, impacting public health and safety positively.
